Match between therapeutic proposal in multidisciplinary tumor board and actual treatment in head and neck cancer.
Eur Ann Otorhinolaryngol Head Neck Dis
; 138(4): 247-252, 2021 Sep.
Article
en En
| MEDLINE
| ID: mdl-33257266
ABSTRACT
OBJECTIVES:
There are few published studies evaluating the quality and outcome of multidisciplinary tumor board (MDTB) decisions. The aim of the present study was to evaluate adherence to MDTB recommendations in head and neck cancer and to document reasons in case of discordance. MATERIAL ANDMETHODS:
We included all patients with newly diagnosed head and neck cancer presented in our MDTB meetings between January 1st and December 31st, 2018, whatever the tumor site, histology type and TNM classification. MDTB recommendations were compared to actual treatment. Discordance was defined as treatment partially or entirely different from the treatment decision recorded in the MDTB minutes.RESULTS:
Board decisions were made for 344 new patients. Complete treatment concordance rate was 91.6% (315/344 patients), with deviation in 29 patients. Reasons for deviation were complications of treatment in 10 cases, patient refusal in 8, and physician's decision in 4 cases. Five patients died before therapy initiation. Mean interval from board discussion to treatment was 21 days, and depended on type of treatment (range, 1 to 74 days).CONCLUSION:
This study shows the importance of evaluating concordance between the protocol proposed in the MDTB and the treatment actually received, to identify factors for deviation and remedy them when possible.Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Neoplasias de Cabeza y Cuello
Tipo de estudio:
Guideline
/
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
Eur Ann Otorhinolaryngol Head Neck Dis
Año:
2021
Tipo del documento:
Article
País de afiliación:
Francia